Aktualʹnaâ Infektologiâ (Apr 2014)

Features of Anemia Pathogenesis in Patients with Chronic Hepatitis C, Receiving Combination Antiviral Therapy

  • D.V. Dontsov,
  • Yu.M. Ambalov,
  • M.A. Proydakov,
  • L.D. Levina,
  • A.V. Usatkin,
  • A.P. Kovalenko,
  • S.D. Perepechay,
  • N.I. Mamedova

DOI
https://doi.org/10.22141/2312-413x.2.03.2014.82361
Journal volume & issue
Vol. 2, no. 2.03
pp. 57 – 60

Abstract

Read online

The use of combination antiviral therapy enables to achieve sustained virologic response in patients with chronic hepatitis C, but in some patients side effects occur during treatment. A special place among the undesirable manifestations of specific therapy for chronic hepatitis C take hematologic syndromes. In this paper we study some features of the pathogenesis of anemia that develops in patients with chronic hepatitis C receiving antiviral drugs.

Keywords